Pancreas Transplantation
📧 Sign up to get email alerts when something new happens for Pancreas Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-12-14Clinical Trial Update: PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus [Phase 4]
Phase 4 trial update evaluating pharmacokinetics of switching from twice-daily tacrolimus to once-daily extended-release tacrolimus in diabe…
-
FDA approval · 2019-01-31FDA Approved: TACROLIMUS — Original Application (Accord Healthcare Inc.)
The FDA approves Accord Healthcare Inc.'s Original Application for tacrolimus (generic tacrolimus) for prevention of organ transplant reject…
-
FDA approval · 2018-11-29FDA Approved: ASTAGRAF XL — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for ASTAGRAF XL (tacrolimus extended-release capsules) from Astellas Pharma US, Inc., expanding/…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients [Phase 4]
Phase 4 clinical trial update evaluating valganciclovir to prevent cytomegalovirus infection in kidney and kidney/pancreas transplant recipi…
-
CLINICAL_TRIALS trial_result · 2015-12-03Clinical Trial Update: GDT Vs ST for Pancreas Transplant Surgery [NA]
A completed clinical trial comparing GDT and ST approaches for pancreas transplantation, sponsored by the University of Manchester.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Advagraf/Prograf Conversion Trial [Phase 4]
A Phase 4 trial evaluating conversion from Prograf to Advagraf in renal and kidney-pancreas transplant patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf® [Phase 2]
A Phase 2 study comparing tacrolimus pharmacokinetics in adult heart, lung, and pancreas transplant recipients treated with Advagraf vs Prog…
-
CLINICAL_TRIALS research · 2014-04-04Clinical Trial Update: CEUS in Kidney and Pancreas Transplantation
This ClinicalTrials.gov update describes a study evaluating contrast-enhanced ultrasound (CEUS) for imaging in kidney and pancreas transplan…
-
FDA approval · 2012-02-06FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas Pharma US, Inc., updating its label to cover transplant-r…
-
FDA approval · 2009-02-13FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for PROGRAF (tacrolimus) from Astellas Pharma US, Inc., indicating an approved change to the existin…
-
CLINICAL_TRIALS trial_result · 2008-08-20Clinical Trial Update: Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation [Phase 4]
Phase 4 clinical trial comparing Histidine-Tryptophan-Ketoglutarate (HTK) solution versus UW Perfusion in pancreas transplantation has compl…